This suggests that, although the intervention was unable to restore the number of CD4+ T lymphocytes, it facilitated the reduction of the immune system activation, which could be beneficial for these patients, given the persistent chronic inflammation characteristics of HIV infection. The gene discussed is CD4; the disease is HIV infectious disease.